|
Summary:
Completion Not Excl. Pharmaceutical Discount Club. According To Section 130A (8) Sgb V By Means Of An Open House Model To The Active Ingredient Formoterol/Aclidinium Bromide (Atc Code According To Who: R03Al05) Country:
Germany
Notice Type:
Tender Notice Deadline:
30 Jun 2026 Posting Date:
11 Mar 2025 |
|
Summary:
Open House Contracts 2025-1 Country:
Germany
Notice Type:
Tender Notice Deadline:
02 May 2025 Posting Date:
11 Mar 2025 |
|
Summary:
Completion Not Excl. Pharmaceutical Discount Club. According To Section 130A (8) Sgb V By An Open House Model To The Active Ingredient Posaconazole (Atc Code According To Who: J02Ac04) Country:
Germany
Notice Type:
Tender Notice Deadline:
31 May 2027 Posting Date:
11 Mar 2025 |
|
Summary:
Completion Not Excl. Pharmaceutical Discount Club. According To Section 130A (8) Sgb V By An Open House Model To The Active Ingredient Trazodone (Atc Code According To Who: N06Ax05) Country:
Germany
Notice Type:
Tender Notice Deadline:
31 May 2027 Posting Date:
11 Mar 2025 |
|
Summary:
Completion Of Non-Exclusive Discount Agreements According To Section 130A (8) Sgb V (Open House Model) Country:
Germany
Notice Type:
Tender Notice Deadline:
01 Mar 2027 Posting Date:
11 Mar 2025 |
|
Summary:
1 / Dlii6 / Pc028 Diagnosticta Laborials Fa. Obspid Country:
Germany
Notice Type:
Tender Notice Deadline:
12 Mar 2025 Posting Date:
10 Mar 2025 |
|
Summary:
Open House Contracts 2025-1 Country:
Germany
Notice Type:
Tender Notice Deadline:
02 May 2025 Posting Date:
10 Mar 2025 |
|
Summary:
Delivery Of 200 Laptops, 200 Docking Stations And 400 Monitors Country:
Germany
Notice Type:
Tender Notice Deadline:
08 Apr 2025 Posting Date:
10 Mar 2025 |
|
Summary:
Completion Of Non-Exclusive Discount Agreements According To Section 130A (8) Sgb V On The Active Ingredients Mentioned With A Final Option In The Context Of The So-Called Open House Process. Country:
Germany
Notice Type:
Tender Notice Deadline:
31 Dec 2026 Posting Date:
07 Mar 2025 |
|
Summary:
Completion Of Non -Exclusive Discount Agreement According To Section 130A (8) Sgb V For The Active Ingredient Evolocumab - Vv83 Country:
Germany
Notice Type:
Tender Notice Deadline:
10 Feb 2027 Posting Date:
07 Mar 2025 |
Most trusted source for Tendering Opportunities and Business Intelligence since 2002